Qin J et al. |
Radiological and clinical findings of 25 patients with invasive pulmonary aspergillosis: retrospective analysis of 2150 liver transplantation cases. |
2012 |
Br J Radiol |
pmid:22496071
|
Ahn KJ et al. |
Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. |
2003 |
Br J Radiol |
pmid:14711782
|
Murphy GJ et al. |
Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. |
2003 |
Br J Surg |
pmid:12808614
|
Middleton SJ et al. |
Adult small intestinal transplantation in England and Wales. |
2003 |
Br J Surg |
pmid:12808622
|
Morris-Stiff GJ et al. |
Sequential changes in plasma selenium concentration after cadaveric renal transplantation. |
2004 |
Br J Surg |
pmid:14991636
|
Wilson CH et al. |
Randomized clinical trial of daclizumab induction and delayed introduction of tacrolimus for recipients of non-heart-beating kidney transplants. |
2005 |
Br J Surg |
pmid:15856479
|
Waller JR et al. |
Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasia. |
2002 |
Br J Surg |
pmid:12390379
|
Brook NR et al. |
Fibrosis-associated gene expression in renal transplant glomeruli after acute renal allograft rejection. |
2003 |
Br J Surg |
pmid:12905557
|
Jain S et al. |
Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. |
2000 |
Br J Surg |
pmid:11091246
|
Bicknell GR et al. |
Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. |
2000 |
Br J Surg |
pmid:11091247
|
White DJ |
Immunosuppression for heart transplantation. |
1993 |
Br. J. Biomed. Sci. |
pmid:7694717
|
Reichert TE et al. |
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. |
1999 |
Br. J. Cancer |
pmid:10555752
|
Andersson Y et al. |
Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. |
2009 |
Br. J. Cancer |
pmid:19773757
|
Chambers CA |
Topical tacrolimus for cutaneous lupus erythematosus. |
2003 |
Br. J. Dermatol. |
pmid:12752154
|
Ludwig E et al. |
New treatment modalities for granuloma faciale. |
2003 |
Br. J. Dermatol. |
pmid:14511001
|
Vecchietti G et al. |
Topical tacrolimus (FK506) for relapsing erosive stomatitis in paraneoplastic pemphigus. |
2003 |
Br. J. Dermatol. |
pmid:12752158
|
Patel NP et al. |
Treatment of eosinophilic pustulosis of infancy with topical tacrolimus. |
2012 |
Br. J. Dermatol. |
pmid:22563626
|
Bens G et al. |
Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption. |
2003 |
Br. J. Dermatol. |
pmid:12890237
|
Reich K et al. |
Topical tacrolimus for pyoderma gangrenosum. |
1998 |
Br. J. Dermatol. |
pmid:9892935
|
Schmitt J et al. |
Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. |
2011 |
Br. J. Dermatol. |
pmid:20819086
|
Sugiura H et al. |
An open study of a lotion formulation to improve tolerance of tacrolimus in facial atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11736904
|
Afshar M et al. |
The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study. |
2013 |
Br. J. Dermatol. |
pmid:22577776
|
Calza AM and Lübbe J |
Tacrolimus ointment-associated alcohol intolerance in infants receiving ethanol-containing medication. |
2005 |
Br. J. Dermatol. |
pmid:15787832
|
Rigopoulos D et al. |
Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. |
2004 |
Br. J. Dermatol. |
pmid:15541087
|
Clayton TH and Harrison PV |
Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. |
2005 |
Br. J. Dermatol. |
pmid:15787840
|
RodrÃguez GarcÃa F et al. |
Generalized pustular psoriasis successfully treated with topical tacrolimus. |
2005 |
Br. J. Dermatol. |
pmid:15787845
|
Remitz A et al. |
Tacrolimus ointment improves psoriasis in a microplaque assay. |
1999 |
Br. J. Dermatol. |
pmid:10417522
|
Braza TJ et al. |
Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study. |
2003 |
Br. J. Dermatol. |
pmid:12828755
|
Danby SG et al. |
The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. |
2014 |
Br. J. Dermatol. |
pmid:24328907
|
Weidinger S et al. |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal. |
2017 |
Br. J. Dermatol. |
pmid:28868633
|
Charman C |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment. |
2017 |
Br. J. Dermatol. |
pmid:28858382
|
Esquivel-Pedraza L et al. |
Treatment of oral lichen planus with topical pimecrolimus 1% cream. |
2004 |
Br. J. Dermatol. |
pmid:15099380
|
Sorgentini C et al. |
Lichen striatus in an adult: successful treatment with tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15099383
|
Dissemond J et al. |
Pimecrolimus in an adhesive ointment as a new treatment option for oral lichen planus. |
2004 |
Br. J. Dermatol. |
pmid:15099387
|
Harth W and Linse R |
Topical tacrolimus in granuloma annulare and necrobiosis lipoidica. |
2004 |
Br. J. Dermatol. |
pmid:15099394
|
Pitt M et al. |
A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema. |
2006 |
Br. J. Dermatol. |
pmid:16704646
|
Kanekura T et al. |
Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. |
2003 |
Br. J. Dermatol. |
pmid:12588393
|
Hashizume H et al. |
Comparable risk of herpes simplex virus infection between topical treatments with tacrolimus and corticosteroids in adults with atopic dermatitis. |
2006 |
Br. J. Dermatol. |
pmid:16704659
|
Vente C et al. |
Erosive mucosal lichen planus: response to topical treatment with tacrolimus. |
1999 |
Br. J. Dermatol. |
pmid:10233234
|
Lyon CC et al. |
Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. |
1999 |
Br. J. Dermatol. |
pmid:10233300
|
Anstey A |
Therapeutic advances and shift in disease paradigm for atopic dermatitis. |
2008 |
Br. J. Dermatol. |
pmid:19036027
|
Koguchi-Yoshioka H et al. |
Intravenous immunoglobulin contributes to the control of antimelanoma differentiation-associated protein 5 antibody-associated dermatomyositis with palmar violaceous macules/papules. |
2017 |
Br. J. Dermatol. |
pmid:28346662
|
Griffiths CE |
Ascomycin: an advance in the management of atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298524
|
Fujimoto N et al. |
Facial lichen striatus: successful treatment with tacrolimus ointment. |
2003 |
Br. J. Dermatol. |
pmid:12653755
|
Harper J et al. |
First experience of topical SDZ ASM 981 in children with atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298537
|
Ueda M et al. |
Successful treatment of amyopathic dermatomyositis with topical tacrolimus. |
2003 |
Br. J. Dermatol. |
pmid:12653761
|
Luger T et al. |
SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. |
2001 |
Br. J. Dermatol. |
pmid:11298538
|
Lan CC et al. |
FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin. |
2004 |
Br. J. Dermatol. |
pmid:15377358
|
Fricain JC et al. |
Long-term efficacy of topical tacrolimus on oral lesions of chronic graft-versus-host disease. |
2007 |
Br. J. Dermatol. |
pmid:17300261
|
Vissers WH et al. |
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. |
2008 |
Br. J. Dermatol. |
pmid:18284400
|
Reitamo S et al. |
0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. |
2004 |
Br. J. Dermatol. |
pmid:15030341
|
Chuh AA |
The application of topical tacrolimus in vesicular pemphigoid. |
2004 |
Br. J. Dermatol. |
pmid:15030368
|
Ormerod AD |
Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern? |
2005 |
Br. J. Dermatol. |
pmid:16181449
|
Lan CC et al. |
FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. |
2005 |
Br. J. Dermatol. |
pmid:16181452
|
Vukmanovic-Stejic M et al. |
Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:16181456
|
Martin-Munoz MF et al. |
Topical treatment tacrolimus and food allergy. |
2005 |
Br. J. Dermatol. |
pmid:16181473
|
Gollnick H et al. |
Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. |
2008 |
Br. J. Dermatol. |
pmid:18341665
|
Hjelmgren J et al. |
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data. |
2007 |
Br. J. Dermatol. |
pmid:17263826
|
Alomar A et al. |
The role of topical calcineurin inhibitors in atopic dermatitis. |
2004 |
Br. J. Dermatol. |
pmid:15548171
|
Mashayekhi S et al. |
The treatment of vulval lichen sclerosus in prepubertal girls: a critically appraised topic. |
2017 |
Br. J. Dermatol. |
pmid:28244087
|
Reitamo S et al. |
A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients. |
2008 |
Br. J. Dermatol. |
pmid:18637898
|
Rigopoulos D et al. |
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. |
2009 |
Br. J. Dermatol. |
pmid:19120329
|
Wataya-Kaneda M et al. |
A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity. |
2011 |
Br. J. Dermatol. |
pmid:21692771
|
Spergel JM et al. |
Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial. |
2007 |
Br. J. Dermatol. |
pmid:17573885
|
Bäumer W et al. |
Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:16029339
|
Niwa Y et al. |
Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. |
2003 |
Br. J. Dermatol. |
pmid:14632799
|
Ko MJ and Chu CY |
Topical tacrolimus therapy for localized bullous pemphigoid. |
2003 |
Br. J. Dermatol. |
pmid:14632824
|
Wollenberg A et al. |
Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. |
2008 |
Br. J. Dermatol. |
pmid:18782316
|
Doss N et al. |
Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. |
2009 |
Br. J. Dermatol. |
pmid:19416227
|
Thaçi D et al. |
Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. |
2008 |
Br. J. Dermatol. |
pmid:18782319
|
Böhm M et al. |
Resolution of lichen aureus in a 10-year-old child after topical pimecrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15327576
|
Leung DY et al. |
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial. |
2009 |
Br. J. Dermatol. |
pmid:19416245
|
Hickey JR et al. |
Does topical tacrolimus induce lentigines in children with atopic dermatitis? A report of three cases. |
2005 |
Br. J. Dermatol. |
pmid:15656817
|
Mancuso G and Berdondini RM |
Localized scleroderma: response to occlusive treatment with tacrolimus ointment. |
2005 |
Br. J. Dermatol. |
pmid:15656828
|
Langeland T and Engh V |
Topical use of tacrolimus and squamous cell carcinoma on the penis. |
2005 |
Br. J. Dermatol. |
pmid:15656830
|
Kreuter A et al. |
Pimecrolimus 1% cream for perianal atopic dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:15656832
|
Fiorentino DF et al. |
The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes. |
2011 |
Br. J. Dermatol. |
pmid:21166661
|
Lewis FM and Neill SM |
Safety of calcineurin inhibitors in the management of lichen sclerosis. |
2007 |
Br. J. Dermatol. |
pmid:17535239
|
Neckermann G et al. |
Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981. |
2000 |
Br. J. Dermatol. |
pmid:10792216
|
Queille-Roussel C et al. |
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. |
2001 |
Br. J. Dermatol. |
pmid:11260007
|
Ramsay HM and Harden PN |
Cyclosporin-induced flushing in a renal transplant recipient resolving after substitution with tacrolimus. |
2000 |
Br. J. Dermatol. |
pmid:10792253
|
Rao A and Bunker C |
Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study. |
2010 |
Br. J. Dermatol. |
pmid:20353455
|
Ellis C et al. |
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. |
2003 |
Br. J. Dermatol. |
pmid:12694268
|
Oji V et al. |
Topical pimecrolimus: a novel therapeutic option for Netherton syndrome. |
2005 |
Br. J. Dermatol. |
pmid:16225628
|
Connolly M and Kennedy C |
Exfoliative cheilitis successfully treated with topical tacrolimus. |
2004 |
Br. J. Dermatol. |
pmid:15270904
|
Healy E et al. |
Cost-effectiveness of tacrolimus ointment in adults and children with moderate and severe atopic dermatitis: twice-weekly maintenance treatment vs. standard twice-daily reactive treatment of exacerbations from a third party payer (U.K. National Health Service) perspective. |
2011 |
Br. J. Dermatol. |
pmid:21083544
|
Tzung TY and Wu JC |
Topical calcineurin inhibitors in treating Jessner's lymphocytic infiltration of the skin: report of a case. |
2005 |
Br. J. Dermatol. |
pmid:15727667
|
Poole CD et al. |
Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study. |
2009 |
Br. J. Dermatol. |
pmid:19754867
|
Chu CY |
The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. |
2005 |
Br. J. Dermatol. |
pmid:15727676
|
Park CW et al. |
Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:15948978
|
Gottlieb AB et al. |
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. |
2005 |
Br. J. Dermatol. |
pmid:15948985
|
Bhol KC and Schechter PJ |
Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:15948987
|
Reitamo S et al. |
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. |
2005 |
Br. J. Dermatol. |
pmid:15948994
|
Wolff K et al. |
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial. |
2005 |
Br. J. Dermatol. |
pmid:15948996
|
Rigopoulos D et al. |
Pimecrolimus 1% cream in the treatment of disseminated granuloma annulare. |
2005 |
Br. J. Dermatol. |
pmid:15949015
|
Kirtschig G et al. |
Successful treatment of erosive vulvovaginal lichen planus with topical tacrolimus. |
2002 |
Br. J. Dermatol. |
pmid:12207624
|
Sigurgeirsson B and Luger T |
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - author response. |
2017 |
Br. J. Dermatol. |
pmid:28940181
|
Ho N et al. |
A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo. |
2011 |
Br. J. Dermatol. |
pmid:21457214
|
Rigopoulos D et al. |
Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study. |
2006 |
Br. J. Dermatol. |
pmid:16792767
|
Weissenbacher S et al. |
Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. |
2007 |
Br. J. Dermatol. |
pmid:17493072
|